Two giants of commercial gene research, Celera Genomics of Rockville,
Maryland, and Geron of Menlo Park, California, signed a deal this week to work
towards growing brand new organs from a patient’s own cells. Geron has a unique
supply of human stem cells, which can theoretically grow into particular sorts
of tissue, while sequencing heavyweight Celera will identify genes which control
tissue formation in embryos. “Our work under this alliance will bring us one
step closer to realising the therapeutic potential of human stem cells,” says
Thomas Okarma, Geron’s president.
To continue reading, today with our introductory offers
Advertisement
More from 51¶¯Âþ
Explore the latest news, articles and features
Popular articles
Trending 51¶¯Âþ articles
1
The Selfish Gene at 50: Why Dawkins’s evolution classic still holds up
2
Mathematicians stunned by AI's biggest breakthrough in mathematics yet
3
Photos reveal unexpected details from the world's first atomic test
4
We may finally know why dinosaurs like T. rex evolved tiny arms
5
Can we harness quantum effects to create a new kind of healthcare?
6
Mystery of the ancient giant stone jars of Laos may have been solved
7
The 3 things you need to know about protein, according to an expert
8
Putting CO2 into rocks and getting hydrogen out is climate double win
9
The ‘doomsday’ glacier’s giant ice shelf is about to break away
10
The distant world that is our best hope of finding alien life
